BIOTECHNOLOGY VALUE FUND L P 13D and 13G filings for Arcus Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 11:58 am Sale | 2022-12-31 | 13G | Arcus Biosciences, Inc. RCUS | BIOTECHNOLOGY VALUE FUND L P | 2,303,520 3.200% | -1,657,428 (-41.84%) | Filing |
| 2022-03-14 4:48 pm Purchase | 2022-03-03 | 13G | Arcus Biosciences, Inc. RCUS | BIOTECHNOLOGY VALUE FUND L P | 3,960,948 5.600% | 1,208,726 (+43.92%) | Filing |
| 2020-12-10 5:16 pm Sale | 2020-02-04 | 13G | Arcus Biosciences, Inc. RCUS | BIOTECHNOLOGY VALUE FUND L P | 2,752,222 4.200% | -826,801 (-23.10%) | Filing |